PIK3CA and breast cancer: In hormone-regulated cancers such as prostate and breast cancer, activation of the PI3K pathway is often driven by mutations/amplification/overexpression of PIK3CA/PIK3CB, or loss of the tumor suppressor PTEN3–6.